Artemisinin-based combination therapy (ACT) is the primary malaria treatment in most malaria-endemic countries. To better understand the current ACT market and supply chain, PATH developed a market landscape with useful market information for stakeholders that purchase, procure, or use ACTs.

The content of this landscape focuses on the current state of the ACT market—including supply, demand, market shares and prices, and active pharmaceutical ingredient and artemisinin suppliers.

PATH hopes this landscape will be a valuable resource for partners, and we welcome any feedback or suggestions on the document.